Newton Biocapital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Neuvasqneuvasq.cominJun 2021✓ verified
Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders.
BiotechDeep TechHealthtechMedical Devices
Benoit Vanhollebeke(Scientific Founder)inDenis Bedoret(Executive Director)in
Co-investorsSambrinvestWallonie Entreprendre
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.